HBK-001

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameHBK-001
Drug Alias NameHBK-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonistsDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IVGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A